Overview

Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Safety and Pharmacokinetics of Oral Artesunate in patients with advanced hepatocellular carcinoma (HCC)
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital, Ghent
Collaborators:
Anticancer Fund, Belgium
University Ghent
Treatments:
Artemisinins
Artesunate